Overcoming Platinum and PARP-Inhibitor Resistance in Ovarian Cancer

Platinum chemotherapy remains the cornerstone of treatment for epithelial ovarian cancer (OC) and Poly (ADP-ribose) polymerase inhibitors (PARPi) now have an established role as maintenance therapy. The mechanisms of action of these agents is, in many ways, complementary, and crucially reliant on th...

Full beskrivning

Sparad:
Bibliografiska uppgifter
Huvudupphovsmän: Michelle McMullen, Katherine Karakasis, Ainhoa Madariaga, Amit M. Oza
Materialtyp: Artigo
Språk:Inglês
Publicerad: MDPI AG 2020-06-01
Serie:Cancers
Ämnen:
resistance mechanisms
platinum
PARP
ovarian cancer
homologous recombination
Länkar:https://www.mdpi.com/2072-6694/12/6/1607
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk